Navigation Links
Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
Date:8/17/2010

MARLBOROUGH, Mass., Aug. 17 /PRNewswire/ -- Block Engineering, a leading developer of mid-infrared spectroscopy sensors, announced today the launch of a family of next-generation, revolutionary spectrometers based on widely tunable quantum cascade lasers (QCLs). Daniel Cavicchio, chairman of Block Engineering, commented, "This announcement is a significant milestone in Block's history and it is the result of a multiyear focused development effort, which was supported by significant government and internal funding. Our customers have received these products very well and we look forward to strong growth over the next few years."

"The applications of QCLs are so broad that we have attracted strong interest from both commercial and government customers," said Adam Erlich, VP of Marketing and Business Development of Block Engineering. "This is the reason for introducing three products at the onset: LaserScan™, which can analyze surface chemistries from a distance of 6 inches to 2 feet; LaserScope™, which is a high-performance IR microscope; and LaserTune™, which is a tunable QCL source used by researchers. Because all these products have enhanced performance versus traditional Fourier Transformed Infrared (FTIR) spectrometers, we are experiencing huge interest among military users, life science researchers, pharmaceutical/chemical companies, plastic products manufacturers and environmental firms."

Petros Kotidis, CEO of Block Engineering, commented, "Block's staff has unique, deep knowledge of spectroscopy, rugged packaging, signal processing and decades of experience in new product introduction for both commercial and government markets. These new products have been developed in record time and I am very pleased to see that we are meeting and exceeding our customers' needs in our new and exciting target markets."

These products will be showcased at the American Chemical Society Exposition in Boston on August 22-26, 2010.

About Block Engineering:

Founded in 1956, Block Engineering is a leading developer of high performance QCL and FT-IR spectrometers for chemical detection and analysis to military, government, commercial, and industrial customers. Its Mobile Chemical Agent Detector (MCAD) system, in partnership with Northrop Grumman Corporation, and, PORTHOS™, a portable FT-IR spectrometer system, remotely detect chemical threats as far as 3 miles and protect against chemical warfare agents and weapons of mass destruction. Following this success, Block has applied its extensive knowledge of spectroscopy and chemical detection towards the commercialization of its high performance QCL based spectrometers. In addition, Block is developing a revolutionary MEMS-based, miniaturized spectrometer, the ChemPen™, which is a low cost, FTIR chemical gas detector the size of a fountain pen.

Block Engineering is headquartered in Marlborough, Massachusetts, USA. For more information, visit www.blockeng.com.

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE Block Engineering
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
2. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
3. CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
4. Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market
5. BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
6. Four Basics and Some Good Information About Beta-Blocker Treatment for High Blood Pressure
7. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
8. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
9. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
10. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
11. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016   ... that Nationwide Children,s Hospital signed a ... and accelerate the development of new cures. ... organizations representing over 57 million patients globally, biopharmaceutical ... working together to improve protocol design, site selection, ...
(Date:12/8/2016)... True Health Diagnostics today announced a ... and management expertise to hospital systems throughout ... doctors and patients to benefit from state-of-the-art biomarker ... Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... to contain costs, have struggled to keep up ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, cancer ... announced the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):